We are live on ! Find out more
HLA

Hamilton Lane Advisors Portfolio holdings

AUM $149M
1-Year Est. Return 14.17%
This Fund
S&P 500
This Quarter Est. Return
-0.31%
1 Year Est. Return
-14.17%
3 Year Est. Return
+186.76%
5 Year Est. Return
+98.42%
10 Year Est. Return
+778.69%
AUM
$265M
AUM Growth
+$45.6M
Cap. Flow
+$56.1M
Cap. Flow %
21.17%
Top 10 Hldgs %
58.36%
Holding
84
New
32
Increased
8
Reduced
14
Closed
24

Top Buys

Rank Stock Value
1
HAPN
Happen Inc
HAPN
+$21.8M
2
CUDA
Barracuda Networks, Inc.
CUDA
+$9.16M
3
BLUE
bluebird bio
BLUE
+$8.46M
4
AR icon
Antero Resources
AR
+$8.23M
5
SAGE
Sage Therapeutics
SAGE
+$6.82M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$17M
2
AGIO icon
Agios Pharmaceuticals
AGIO
+$7.58M
3
TWTR
Twitter, Inc.
TWTR
+$6.36M
4
NMBL
Nimble Storage, Inc.
NMBL
+$5.5M
5
VEEV icon
Veeva Systems
VEEV
+$3.57M

Sector Composition

Rank Sector Weight
1 Communication Services 25.87%
2 Healthcare 22.64%
3 Technology 13.03%
4 Financials 12.86%
5 Consumer Discretionary 3.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RLYP
51
DELISTED
RELYPSA INC COM
RLYP
$444K 0.17%
13,411
-18,636
-58% -$641K
TTPH
52
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$352K 0.13%
+371
New +$303K
SUPN icon
53
Supernus Pharmaceuticals
SUPN
$2.6B
$319K 0.12%
+18,806
New +$268K
CHGG icon
54
Chegg
CHGG
$113M
$308K 0.12%
+39,334
New +$311K
ACHN
55
DELISTED
Achillion Pharmaceuticals
ACHN
$264K 0.1%
+29,846
New +$282K
NVAX icon
56
Novavax
NVAX
$1.21B
$235K 0.09%
1,054
– –
INGN icon
57
Inogen
INGN
$168M
$228K 0.09%
+5,114
New +$196K
CALA
58
DELISTED
Calithera Biosciences, Inc
CALA
$71K 0.03%
+500
New +$116K
TOVX icon
59
Theriva Biologics
TOVX
$9.44M
$68K 0.03%
3
– –
AGIO icon
60
Agios Pharmaceuticals
AGIO
$1.91B
– –
-80,439
Closed -$7.58M
CDNA icon
61
CareDx
CDNA
$2.23B
– –
-10,244
Closed -$57K
CRTO icon
62
Criteo S.A. Ordinary Shares
CRTO
$1.09B
– –
-18,900
Closed -$747K
FOLD
63
DELISTED
Amicus Therapeutics
FOLD
– –
-98,119
Closed -$1.07M
GEVO icon
64
Gevo
GEVO
$360M
– –
-17
Closed -$20K
HNRG icon
65
Hallador Energy
HNRG
$676M
– –
-18,664
Closed -$218K
NOAH
66
Noah Holdings
NOAH
$577M
– –
-45,684
Closed -$1.07M
PAYC icon
67
Paycom
PAYC
$7.57B
– –
-10,877
Closed -$349K
TPST icon
68
Tempest Therapeutics
TPST
$13.9M
– –
-6
Closed -$569K
VEEV icon
69
Veeva Systems
VEEV
$32.9B
– –
-140,000
Closed -$3.57M
VTLE
70
DELISTED
Vital Energy
VTLE
– –
-1,474
Closed -$384K
XNET
71
Xunlei
XNET
$332M
– –
-90,003
Closed -$573K
TVRD
72
Tvardi Therapeutics
TVRD
$19.1M
– –
-1,659
Closed -$600K
TTOO
73
DELISTED
T2 Biosystems, Inc
TTOO
– –
-13
Closed -$997K
AERI
74
DELISTED
Aerie Pharmaceuticals
AERI
– –
-23,475
Closed -$736K
JMEI
75
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
– –
-1,400
Closed -$221K
1 2
3
4

Similar funds

FFS
Flavin Financial Services Melbourne, Florida $149M AUM 14.79% 1-Year Est. Return
KCM
KM Capital Management Austin, Texas $149M AUM 18.7% 1-Year Est. Return
GCA
Gallagher Capital Advisors Argyle, Texas $148M AUM 20.92% 1-Year Est. Return
DAC
Dutch Asset Corp Selkirk, New York $149M AUM
RCM
Rockbridge Capital Management Alexandria, Virginia $149M AUM 1.06% 1-Year Est. Return
AWA
Authentikos Wealth Advisory Morgan Hill, California $148M AUM 9.86% 1-Year Est. Return
JWM
Jacksonville Wealth Management Jacksonville, Florida $148M AUM 23.77% 1-Year Est. Return
AWF
Alpha Wealth Funds Park City, Utah $149M AUM 10.03% 1-Year Est. Return

Hamilton Lane Advisors's Q2 2015 Portfolio in Review

As of Q2 2015, Hamilton Lane Advisors held 84 positions worth $265M, up 21% from $219M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Hamilton Lane Advisors deployed $56.1M of net new capital in Q2 2015, opening 32 new positions and adding to 8 existing holdings. Its largest new stake was Happen Inc: 244,118 shares worth $18M.

By sector, the portfolio is most concentrated in Communication Services at 26% of assets, down from 44% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $17M trimmed.

  • Hamilton Lane Advisors's largest Q2 2015 buy was Happen Inc: 244,118 shares worth $18M.
  • Hamilton Lane Advisors added most to Barracuda Networks, Inc. in Q2 2015, an estimated $9.16M increase.
  • Hamilton Lane Advisors's biggest Q2 2015 reduction was Meta Platforms (Facebook), cutting an estimated $17M.
  • Hamilton Lane Advisors fully exited Agios Pharmaceuticals in Q2 2015, selling an estimated $7.58M.
  • Hamilton Lane Advisors's ten largest holdings make up 58% of its $265M portfolio in Q2 2015.
  • Hamilton Lane Advisors opened 32 new positions and closed 24 in Q2 2015.
  • Hamilton Lane Advisors's portfolio value rose 21% quarter-over-quarter to $265M.

Based on Hamilton Lane Advisors's 13F filing for Q2 2015, filed 23 Jul 2015.